Buy KLOW Peptide Blend Online
KLOW is a four-peptide research blend containing KPV, GHK-Cu, BPC-157, and TB-500. It expands on the GLOW concept by adding KPV, a tripeptide studied primarily for inflammatory signaling and intestinal research.
Product Information
KPV is the C-terminal tripeptide of alpha-MSH and has been studied for effects on inflammatory signaling. GHK-Cu contributes to matrix remodeling, while BPC-157 and TB-500 contribute to tissue-repair research pathways.
Importantly, no controlled human trial has tested the four-peptide KLOW combination itself.
How Does It Work?
KLOW combines KPV’s anti-inflammatory signaling with GHK-Cu matrix remodeling and BPC-157/TB-500 repair pathways.
Benefits
Inflammation Research
KPV has been studied in intestinal and cellular inflammation models, particularly for its effects on inflammatory mediators and NF-κB-related signaling.
Skin and Collagen Research
GHK-Cu contributes to research into collagen, extracellular matrix, and skin remodeling, making it particularly relevant to cosmetic and tissue studies.
Tissue-Repair Research
BPC-157 and TB-500 contribute to research into tendon, ligament, muscle, and wound-healing pathways.
Multi-Pathway Research
KLOW brings together four distinct biological pathways in one blend. That makes it interesting experimentally, but claims about synergy remain theoretical because the combination has not been clinically tested.
Side Effects
Reported effects include headache, fatigue, nausea, dizziness, and injection-site irritation. Individual peptide tolerability does not establish the safety of the combined formulation.
Dosage
KLOW formulations vary. A commonly marketed composition is GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg + KPV 10 mg, but this describes vial composition rather than a validated human dose.
Community protocols generally calculate dosing separately for each constituent rather than treating KLOW as one active ingredient.
Research References
Kannengiesser K, et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflamm Bowel Dis. 2008.
PubMed — KPV Research
Pickart L. The human tripeptide GHK and tissue remodeling.
PubMed — GHK-Cu Research
Purerawz Disclaimer
Purerawz does not sell, manufacture, stock, dispense, or directly supply any of the products discussed on this website. Purerawz is an independent information and affiliate platform. Where available, links may direct readers to independent third-party providers, and Purerawz may receive a commission from qualifying purchases at no additional cost to the reader.
The information provided is for educational and informational purposes only. Dosage figures may reflect published research protocols, historical clinical use, or reported community practices and should not be interpreted as personalized medical instructions. Research findings—particularly those from animal, cellular, or small early-stage studies—do not establish that a product is safe or effective for every individual or condition.
